Archive · 29 Jul 2026
Biocon Gets Canada Approval for Yesintek Autoinjector
Biocon, a big medicine company from India, just got permission from Canada to sell a new autoinjector called Yesintek.
This autoinjector helps people with diseases like psoriasis and Crohn's disease.
It's a big deal because it gives patients another way to get their medicine, and it shows Biocon is serious about helping people around the world.
The company has been around for a long time and sells medicines in lots of countries.
Even though their stock went down a little today, it has gone up a lot in the last few months.
Biocon's Canadian subsidiary received Notice of Compliance (NOC) from Health Canada for Yesintek autoinjector.
The approval expands Biocon's biosimilar portfolio in Canada and provides a new treatment option for autoimmune diseases.
Yesintek autoinjector is available in 45 mg/0.5 mL and 90 mg/mL strengths.
The product is indicated for moderate to severe plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis.
Biocon aims to improve patient access to cost-effective treatment options for autoimmune diseases.
- Who
- Biocon, a global biopharmaceutical company
- What
- Received approval for Yesintek autoinjector in Canada
- When
- Approval granted by Health Canada
- Where
- Canada
- Why
- To expand its biosimilar portfolio and provide a new treatment option for autoimmune diseases
Biocon's Expansion
Market Competition
Market Expansion
Biocon's Expansion
Biocon's approval for Yesintek autoinjector expands its biosimilar portfolio in Canada, providing a new treatment option for autoimmune diseases.
Market Competition
The approval may face competition from existing treatments and other biosimilar products in the Canadian market.
- Company
- Biocon
- Approval
- Notice of Compliance (NOC) from Health Canada
- Product
- Yesintek (ustekinumab) Autoinjector
- Strengths
- 45 mg/0.5 mL and 90 mg/mL
- Indications
- Plaque psoriasis, psoriatic arthritis, Crohn’s disease, ulcerative colitis
- Headquarters
- Bengaluru, India
- Founded
- 1978
- Market Presence
- More than 120 countries